Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1999-04-14
2000-11-07
Horlick, Kenneth R.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 912, 530300, 530350, 536 231, 536 241, C12Q 168, C12P 1934, C07H 2104
Patent
active
061435031
ABSTRACT:
Engineered mRNA useful in producing libraries of engineered mRNAs, polypeptide-engineered mRNA conjugates and diverse encoded polypeptide libraries, as well as novel ribozymes that join an mRNA to the translation product of the mRNA and methods of identifying members of diverse encoded polypeptide libraries which exhibit a desired activity. Also described are polypeptide-nucleic acid tag conjugates, methods of producing the conjugates and uses therefor.
REFERENCES:
patent: 5728818 (1998-03-01), Wincott et al.
Sigma Catalog, pp. 1030-1034 and 1818, 1993.
Zhang et al., Nature 390, 96-100 (1997).
Lohse et al., Nature 381, 442-444 (1996).
Wang, Z. and Rana, T.M., "RNA-protein interactions in the Tat-trans-activation response element complex determined by site-specific photo-cross-linking," Biochemistry 37(12) :4235-4243, (1998).
Naryshkin, N.A., et al. "Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues," Biochemistry 36(12) :3496-3505, (1997).
Ye, X., et al., "Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex," Chem Biol 2(12) :827-840, (1995).
Bartel, D.P. and Szostak, J.W., "Isolation of new ribozymes from a large pool of random sequences," Science 261(5127) :1411-1418 (1993).
Farrow, M.A., et al., "Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes," Biochemistry 37(9) :3096-3108, (1998).
Melekhovets, Y.F. and Joshi, S., "Fusion with an RNA binding domain to confer target RNA specificity to an RNase: design and engineering of Tat-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro," Nucleic Acids Res 24(10) :1908-1912, (1996).
Liu, Y., et al., "Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking," J. Biol. Chem. 271(17) :10391-10396, (1996).
Srinivasan, J., et al., "A docking and modelling strategy for peptide-RNA complexes: applications to BIV Tat-TAR and HIV Rev-RBE," Fold Des 1(6) :463-472, (1996).
Hager, A.J. and Szostak, J.W., "Isolation of novel ribozymes that ligate AMP-activated RNA substrates," Chem. Biol. 4(8) :607-617, (1997).
Zhang, B. and Cech, T.R., "Peptide bond formation by in vitro selected ribozymes," Nature 390(6655) :96-100, (1997).
Roberts, R.W. and Szostak, J.W., "RNA-peptide fusion for the in vitro selection of peptides and proteins," Proc. Natl. Acad. Sci. USA, 94(23) :12297-12302 (Nov. 1997).
Nemoto, N., et al., "In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro," FEBS Lett 414(2) :405-8 (Sep. 1997).
Bartel David P.
Baskerville Donald Scott
Horlick Kenneth R.
Whitehead Institute for Biomedical Research
LandOfFree
Use of a ribozyme to join nucleic acids and peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a ribozyme to join nucleic acids and peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a ribozyme to join nucleic acids and peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1639207